Skip to content
JeKo-1
Tissue
Peripheral blood
Disease
Mantle cell lymphoma
Synonyms
Jeko-1, JEKO-1, JeKo 1, Jeko1, JEKO1, JEKO

Documents

JeKo-1

Cell line · Product number 305078

The JeKo-1 cell line is an established human mantle cell lymphoma (MCL) cell line derived from an adult patient. Mantle cell lymphoma is a type of non-Hod...

€430.00excl. tax and shipping

Customization / Recommendations

In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

The JeKo-1 cell line is an established human mantle cell lymphoma (MCL) cell line derived from an adult patient. Mantle cell lymphoma is a type of non-Hodgkin lymphoma characterized by the overexpression of cyclin D1 due to the t(11;14)(q13;q32) chromosomal translocation. JeKo-1 cells exhibit this hallmark genetic aberration, making them a valuable model for studying the pathophysiology of MCL and testing therapeutic agents targeting the cyclin D1 pathway. These cells grow in suspension and possess a doubling time that facilitates robust experimental use in various high-throughput screening applications.

JeKo-1 cells are particularly useful in research focused on the molecular mechanisms of MCL, including the exploration of B-cell receptor (BCR) signaling pathways, apoptosis resistance, and drug resistance mechanisms. Additionally, this cell line serves as a model for studying the interaction between tumor cells and the microenvironment, especially in the context of lymphoid malignancies. Due to its well-characterized genetic background and consistent behavior in vitro, JeKo-1 is frequently utilized in the development and testing of novel anti-cancer compounds, particularly those aimed at overcoming chemoresistance in MCL.

Tissue
Peripheral blood
Disease
Mantle cell lymphoma
Synonyms
  • Jeko-1
  • JEKO-1
  • JeKo 1
  • Jeko1
  • JEKO1
  • JEKO

02Classification

Organism
Human
Sex
Female
Growth properties
Suspension
Biosafety level
1

03Characteristics

Morphology
Lymphoblast

04Identifiers

Citation
JeKo-1 (Cytion catalog number 305078)
NCBI TaxID
9606
Cellosaurus
CVCL_1865

05Expression and susceptibility

Protein expression
Cd3-, Cd5+, Cd10+, Cd19+
Antigen expression
CD3-, CD5+, CD10+, CD19+

06Handling and culture

Culture medium
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 20% heat-inactivated FBS
Subculturing
Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 5 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation.
Fluid renewal
2 to 3 times per week
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
78 years